Nachtnebel, A. (2014): Horizon Scanning in Oncology: Results of the 21st Prioritisation – 4th quarter 2014. HSO: 21st Prioritisation.
|PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader|
For the 21st prioritisation (December 2014), 12 were filtered out of 169 identified drugs and were sent to prioritisation. Of these, 6 drugs were ranked as "highly relevant" by the expert panel, 5 as "relevant" and 1 as "not relevant". For "highly relevant" drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.
|Item Type:||DSD: Horizon Scanning in Oncology|
|Subjects:||WB Practice of medicine > WB 300-962 Therapeutics|
QZ Pathology > QZ 200-380 Neoplasms.Cysts
|Series Name:||HSO: 21st Prioritisation|
|Deposited on:||14 Jan 2015 14:42|
|Last Modified:||14 Jan 2015 14:42|
Repository Staff Only: item control page